Ideal Cures adds new manufacturing facility at 'tax holiday' location
Ideal Cures has added a fourth manufacturing location at Sikkim in India to meet the demand of its local customers and to expand its global customer base.
Archives for November 28, 2016
Japan to share API plant inspection data with international regulators
European Union and Japanese regulators have announced they will share details of API manufacturing facility inspections.
Nitika to build 4th excipients plant near emerging Indian export hub
Nitika Pharmaceutical Specialties Pvt Ltd has said it will build a fourth pharmaceutical excipients plant in Nagpur, India.
Catalent adding OTC capsule maker Accucaps to global softgel network
Catalent will add two Canadian manufacturing facilities to its softgel network through the acquisition of Accucaps.
US FDA clears Lupin to supply US with meds made in Goa
The US FDA has cleared Lupin to restart production of drugs for the US market at its plant in Goa after the Indian firm fixed problems observed by agency inspectors.
Compounding issues: gov’t watchdog releases drug compounding report
The FDA is still in “the early stages” of overseeing 503B outsourcing facilities, but efforts continue as concerns surround the oversight of drug compounders, according to a recent report by the US Government Accountability Office (GAO).
The impact of particles on pharmaceuticals
Paid for and content provided by RSSL
Sometimes it's the smallest details that have the biggest impact on pharmaceutical performance. That's certainly true when it comes down to the properties of particles and their impact on pharmaceutical performance. Subtle changes in particle size, shape...
Pfizer axes parts of $425m Irish expansion after dropping PCSK9 inhibitor
Plans to build a five-story biomanufacturing plant in Ireland could be shelved following the clinical failure of Pfizer's proposed cholesterol-lowering candidate bococizumab.